National Research (NASDAQ:NRC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of National Research (NASDAQ:NRC) from a hold rating to a buy rating in a report published on Saturday.

Several other equities analysts have also recently issued reports on NRC. Citizens Jmp boosted their price target on National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 29th. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $26.00.

National Research Stock Down 0.1%

Shares of NASDAQ:NRC opened at $19.50 on Friday. National Research has a 1-year low of $11.01 and a 1-year high of $23.68. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. The stock has a market cap of $443.62 million, a P/E ratio of 78.00 and a beta of 0.34. The firm has a fifty day moving average price of $20.45 and a 200 day moving average price of $18.30.

National Research (NASDAQ:NRC) last announced its earnings results on Tuesday, July 28th. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.46. National Research had a net margin of 4.18% and a return on equity of 142.50%. The business had revenue of $35.39 million during the quarter, compared to analysts’ expectations of $34.90 million.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 9th. Shareholders of record on Friday, September 25th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 25th. This represents a $0.64 dividend on an annualized basis and a yield of 3.3%. National Research’s dividend payout ratio (DPR) is 256.00%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. grew its holdings in shares of National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of National Research by 9,535.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after buying an additional 1,621 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of National Research by 85.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after buying an additional 1,150 shares during the last quarter. Strs Ohio purchased a new stake in shares of National Research in the 1st quarter worth about $33,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of National Research in the 2nd quarter worth about $34,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.